We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$643M
2
T icon
AT&T
T
+$311M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$306M
4
MSFT icon
Microsoft
MSFT
+$292M
5
AME icon
Ametek
AME
+$215M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$887M
2
AAPL icon
Apple
AAPL
+$694M
3
PRAH
PRA Health Sciences, Inc.
PRAH
+$616M
4
AMZN icon
Amazon
AMZN
+$596M
5
LIN icon
Linde
LIN
+$531M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRWG icon
3001
GrowGeneration
GRWG
$95.5M
$4.29M ﹤0.01%
173,990
+149,244
+603% +$5.27M
NX icon
3002
Quanex
NX
$892M
$4.29M ﹤0.01%
200,440
+110,623
+123% +$2.58M
BKKT icon
3003
Bakkt Inc
BKKT
$347M
$4.29M ﹤0.01%
16,971
+14,659
+634% +$3.68M
XPEL icon
3004
XPEL
XPEL
$1.37B
$4.29M ﹤0.01%
56,507
-17,885
-24% -$1.47M
NCLH icon
3005
CALL
Norwegian Cruise Line
NCLH
$7.65B
$4.28M ﹤0.01%
+160,100
New +$4.07M
KEYS icon
3006
CALL
Keysight
KEYS
$54.5B
$4.27M ﹤0.01%
+26,000
New +$4.36M
NTES icon
3007
CALL
NetEase
NTES
$78.6B
$4.27M ﹤0.01%
50,000
– –
THRN
3008
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$4.26M ﹤0.01%
+492,928
New +$4.02M
OLO
3009
DELISTED
Olo Inc
OLO
$4.26M ﹤0.01%
141,866
+128,347
+949% +$4.58M
ARCT icon
3010
Arcturus Therapeutics
ARCT
$432M
$4.26M ﹤0.01%
+89,075
New +$3.99M
SYRE icon
3011
Spyre Therapeutics
SYRE
$7.97B
$4.25M ﹤0.01%
21,409
-318
-1% -$55.6K
PSPC
3012
DELISTED
Post Holdings Partnering Corporation
PSPC
$4.25M ﹤0.01%
+441,370
New +$4.28M
AUDC icon
3013
AudioCodes
AUDC
$242M
$4.25M ﹤0.01%
130,676
+26,640
+26% +$864K
RSKD icon
3014
Riskified
RSKD
$833M
$4.25M ﹤0.01%
+186,398
New +$5.23M
JYAC
3015
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.25M ﹤0.01%
435,713
– –
SGEN
3016
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$4.25M ﹤0.01%
+25,000
New +$3.89M
NBP
3017
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$4.24M ﹤0.01%
58,529
+32,669
+126% +$2.36M
PRG icon
3018
PROG Holdings
PRG
$1.56B
$4.24M ﹤0.01%
100,869
+14,365
+17% +$645K
FTPAU
3019
DELISTED
FTAC Parnassus Acquisition Corp. Unit
FTPAU
$4.23M ﹤0.01%
425,000
-4
-0% -$40
NVSA
3020
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$4.23M ﹤0.01%
433,623
+81,502
+23% +$789K
DAWN
3021
DELISTED
Day One Biopharmaceuticals
DAWN
$4.22M ﹤0.01%
+177,945
New +$4.26M
JBTM
3022
JBT Marel
JBTM
$6.14B
$4.22M ﹤0.01%
30,012
-14,245
-32% -$2.04M
PRPC.U
3023
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$4.21M ﹤0.01%
423,156
-128,073
-23% -$1.28M
ALTR
3024
DELISTED
Altair Engineering Inc
ALTR
$4.21M ﹤0.01%
61,009
-84,953
-58% -$6.06M
XPEV icon
3025
PUT
XPeng
XPEV
$11B
$4.2M ﹤0.01%
118,200
+40,000
+51% +$1.59M
119 120
121
122 123

Similar funds

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.